WHITEPAPER DOWNLOAD
Closing the Diagnostic Gap: How DTC Clinical AI Accelerates Patient Finding and Treatment in Multiple Sclerosis
Millions with Multiple Sclerosis (MS) face significant diagnostic delays. Discover how AI-powered patient finding helps identify probable cases earlier and connect patients to appropriate care. Scroll to see how it works ↓
We respect your privacy. Your information will not be shared.
From Uncertainty to Care, Faster
Most people with MS experience long diagnostic delays, with many remaining untreated for years.
Ada’s clinical AI engages individuals at first symptoms, detects patterns that may indicate MS, and prompts timely follow-up with specialists. This gives pharma partners a scalable way to reach underdiagnosed populations, increase patient activation, and support earlier access to appropriate therapy.